Furthermore, breast cancer cells secrete RANKL to facilitate osteoclast formation both in vitro and vivo.16 The administration of dual drugs inhibited osteoclast formation significantly compared with individual PL or ZA when BMMs and hPBMCs were induced with RANKL directly and MDA-MB-231, respectively. This evidence concerns the gene TNFSF11 and breast cancer.